CORRESP 1 filename1.htm CORRESP

Jefferies LLC

520 Madison Avenue

New York, New York 10022

  

SVB Leerink LLC

One Federal Street, 37th Floor

Boston, Massachusetts 02110

  

Credit Suisse Securities (USA) LLC

Eleven Madison Avenue

New York, New York 10010-3629

December 8, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Forma Therapeutics Holdings, Inc.

Acceleration Request for Registration Statement on Form S-1

File No. 333-251198

Dear Sir/Madam:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of Preliminary Prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

In accordance with Rule 461 of the Act, we hereby join in the request of Forma Therapeutics Holdings, Inc. for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 5:00 p.m. Eastern time on December 10, 2020, or as soon thereafter as practicable.

[Remainder of page intentionally left blank]


Very truly yours,

 

By:   JEFFERIES LLC
By:  

/s/ Dustin Tyner

  Name: Dustin Tyner
  Title: Managing Director
By:   SVB LEERINK LLC
By:  

/s/ Irena Melnikova

  Name: Irena Melnikova
  Title: Managing Director
By:   CREDIT SUISSE SECURITIES (USA) LLC
By:  

/s/ Rebecca Kotkin

  Name: Rebecca Kotkin
  Title: Director

[Signature page to Acceleration Request Letter]